Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AMES Treatment of the Impaired Leg in Chronic Stroke Patients

NCT01378637 is registered in ClinicalTrials.gov with AMES Technology as lead sponsor.

NCT NCT01378637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01378637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AMES Treatment of the Impaired Leg in Chronic Stroke Patients
Lead sponsor
AMES Technology
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2011
Completion date
July 31, 2017
Enrollment
22 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular accident, hemiparesis, stroke